Back to search

Article

Deep generative design of neutralizing nanobodies against SARS-CoV-2 variants

2024-10-30

Abstract excerpt

In recent years, single-domain heavy chain antibodies (nanobodies), with only one-tenth the molecular weight of conventional antibodies, have emerged as important therapeutic proteins in the fight against SARS-CoV-2. However, the rapid mutation of the virus often renders existing nanobodies ineffective, underscoring the need to develop nanobodies that specifically target new variants. Traditional methods for disco...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
68876211-83f0-508a-9638-d5295ca89c37
DOI
10.1101/2024.10.29.620982
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Deep generative design of neutralizing nanobodies against SARS-CoV-2 variantsDOI 10.1101/2024.10.29.620982
Select a neighboring publication to make it the new centre.